Search

We are passionate about embracing and celebrating the diversity of everybody in the Peter Mac community Celebrating difference At Peter MacCallum... Read more

ProsTIC clinical trials currently open LuCAB: Cabazitaxel in combination with 177Lu-PSMA-617 in metastatic castration-resistant prostate cancer: A Phase I/II study ... Read more

ProsTIC Leadership Team Professor Michael Hofman - Director of Prostate Cancer Theranostics and Imaging Centre of Excellence (ProsTIC); Nuclear Medicine and Molecular Imaging Physician  Professor Declan Murphy - Director... Read more

  The Australian Cancer Survivorship Centre (ACSC) together with Victorian Cancer Agency (VCA) invites registrations to this virtual Victorian Cancer Survivorship Research Forum. This forum is an opportunity for... Read more

Peter MacCallum Cancer Centre and Cartherics Pty Ltd have entered into a Collaborative Development Program Agreement (CDPA) to develop Cartherics’ proprietary autologous CAR T-cell therapy (CTH-001) for the... Read more

The Australian Drosophila Transgenic Facility (ADTF), supported by Phenomics Australia and Peter MacCallum Cancer Centre, offers specialised microinjection services for generating transgenic strains of the fruit fly Drosophila... Read more